DUBLIN--(BUSINESS WIRE)-- The "US Rosacea Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive insights into Rosacea pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Rosacea market size and drug sales. This research also provides insights into Rosacea epidemiology and late stage pipeline.

The research is classified into following sections - Rosacea overview with definitions, symptoms, etiology, diagnosis, treatment options; Rosacea pipeline insights covering late stage clinical trials pipeline; Rosacea prevalence trends by countries; Rosacea market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope

• Rosacea pipeline: Find out the drugs in clinical trials for Rosacea by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Rosacea epidemiology: Find out the prevalence of Rosacea in US; prevalence forecast to 2023
• Rosacea products: Identify key products marketed and prescribed for Rosacea by brand name, by molecule, by company, by branded / generic, in US
• Rosacea market size: Find out the market size for Rosacea drugs in US; Find out how the market advanced from 2014
• Rosacea drug sales: Find out the sales of Rosacea drugs in US
• Rosacea drugs sales forecast: Sales forecast for Rosacea drugs to 2023 in US
• Rosacea market share analysis: Find out the market shares of Rosacea drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/5kfv9j/rosacea_united?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181011005567/en/

Report Abuse